The National Institute of Health (NIH) has doubled its budget allocation in a 5-year period.
This increase has influenced all components of the NIH budget, all institutes, and all areas of medical research.
|Liver disease research represents 1.4% of the total NIH budget.|
However, during the past 5 years the funding of liver disease research has more than doubled. It has risen from $179.9 million (1998) to $377.7 million (2003).
Currently, liver disease research represents 1.4% of the total NIH budget. This is spread between 16 of the NIH's 27 institutes and centers.
In 2002, the NIH budget funded a total of 1,646 grants, agreements, contracts, fellowships, and awards in liver disease research. The largest numbers of grants were in viral hepatitis and infectious diseases, liver cancer, and basic cellular and molecular biology of the liver.
Dr Jay Hoofnagle of the National Institutes of Health, Bethesda, Maryland, comments that the "Budget and current portfolio demonstrate the depth and breath of liver disease research funding by the NIH".
He concludes, "For the liver disease research community, it is important to respond to this increased Federal commitment to liver disease-related research with real progress in our understanding of liver diseases and better means of their diagnosis, prevention, cure, and control".